Aoyama Takashi
Dietary Department, Shizuoka Cancer Center, Shizuoka, Japan.
Nutr Metab Insights. 2022 May 17;15:11786388221098507. doi: 10.1177/11786388221098507. eCollection 2022.
We explored the benefits of a digitized bedside terminal with a touchscreen for selectable hospital meals called "à la carte digital-select" in cancer chemotherapy patients. The subjects used "à la carte digital-select" for 35 days, from November to December 2015. On average, 253 (between 196 and 288) patients accessed this system per day, and 40 patients used it daily (15.9%). Subjects included 75 patients (cancer chemotherapy: chem-digital-select patients, female: 47) and 12 patients (concurrent chemo radiotherapy: CRT-digital-select patients, female: 6) with a repeat rate of 87% (65) and 100% (12). The average length of hospital stay in chem-digital-select patients was 6 days (1-35), the average number of days using "à la carte digital-select" was 3 days (1-24); a correlation was observed between these factors ( = .80; < .01). The eating rate of chemotherapy patients and CRT-digital-select patients was high (81%, 81%), and no differences were observed between the rate in the cisplatin group (80%) with 28 patients, the non-cisplatin group (81%) with 47 patients, CRT-digital-select patients (81%) with 12 patients ( = .59; ANOVA). Registered dietitians provided no nutritional intervention in any of the cases. We found that "à la carte digital-select" can contribute to supporting cancer chemotherapy and the dietary needs of cancer patients undergoing chemotherapy.
我们探讨了配备触摸屏的数字化床边终端对癌症化疗患者选择“数字点餐式”医院膳食的益处。研究对象在2015年11月至12月期间使用“数字点餐式”系统35天。平均每天有253名（196至288名之间）患者访问该系统，40名患者每天使用（15.9%）。研究对象包括75名患者（癌症化疗：化疗数字点餐式患者，女性47名）和12名患者（同步放化疗：CRT数字点餐式患者，女性6名），重复使用率分别为87%（65名）和100%（12名）。化疗数字点餐式患者的平均住院天数为6天（1至35天），使用“数字点餐式”的平均天数为3天（1至24天）；观察到这些因素之间存在相关性（r = 0.80；P < 0.01）。化疗患者和CRT数字点餐式患者的进食率较高（81%，81%），28名患者的顺铂组（80%）、47名患者的非顺铂组（81%）和12名患者的CRT数字点餐式患者组之间的进食率无差异（F = 0.59；方差分析）。所有病例中注册营养师均未提供营养干预。我们发现“数字点餐式”有助于支持癌症化疗以及癌症化疗患者的饮食需求。
